Bright Green News

Bright Green (BGXX.US): The 2023 Q4 earnings report achieved revenue of $0, with a previous value of $0; earnings per share of -$0.03, with a previous value of -$0.01.

Bright Green (BGXX.US): The 2023 Q4 earnings report achieved revenue of $0, with a previous value of $0; earnings per share of -$0.03, with a previous value of -$0.01.

Zhitong FinanceApr 17 14:50

323 drugs, hurry up! America is facing the biggest “drug shortage” in history...

The US now seems to be facing an unprecedented “drug shortage”...

cls.cnApr 15 14:37

12 Health Care Stocks Moving In Thursday's After-Market Session

GainersOntrak (NASDAQ:OTRK) shares increased by 18.7% to $0.45 during Thursday's after-market session. The company's market cap stands at $18.9 million. Ocuphire Pharma (NASDAQ:OCUP) stock rose 7.82%

BenzingaApr 12 04:31

Bright Green Corp. Enhances CEO's Compensation and Incentives

TipRanksApr 3 18:24

12 Health Care Stocks Moving In Friday's After-Market Session

GainersSalarius Pharmaceuticals (NASDAQ:SLRX) shares rose 33.9% to $0.83 during Friday's after-market session. The market value of their outstanding shares is at $3.2 million. Masimo (NASDAQ:MASI) sha

BenzingaMar 23 05:33

Bright Green to Install 102-megawatt Solar Power Generation Field

Seeking AlphaMar 14 21:28

12 Health Care Stocks Moving In Thursday's Pre-Market Session

GainersAptorum Gr (NASDAQ:APM) shares moved upwards by 47.1% to $6.37 during Thursday's pre-market session. The company's market cap stands at $33.0 million. Nuvectis Pharma (NASDAQ:NVCT) stock moved

BenzingaMar 14 21:06

BRIGHT GREEN ANNOUNCES ITS EXPANSION CONTINUATION WITH A $100 MILLION SOLAR POWERED GENERATION FIELD TO SUPPLY HEAT AND ELECTRICITY TO ITS DRUG PRODUCTION AND MANUFACTURING FACILITY.

GRANTS, NEW MEXICO, March 14, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ:BGXX) ("Bright Green" or the "Company") Today announced that BGXX will install a 102-megawatt solar field to power the electricity

GlobeNewswireMar 14 21:00

12 Health Care Stocks Moving In Wednesday's After-Market Session

GainersMolina Healthcare (NYSE:MOH) stock moved upwards by 24.2% to $503.11 during Wednesday's after-market session. The company's market cap stands at $29.3 billion. Evoke Pharma (NASDAQ:EVOK) shares

BenzingaMar 14 05:32

Regulus Phase 1 Data; Bright Green BGXX Agreement

BioPharmCatalystMar 13 02:36

Trending Stocks Today: Regulus Therapeutics Shoots up 90.57%

March 12th - US stocks trending in regular trading hours.Gainers: $Regulus Therapeutics(RGLS.US)$ shoots up 90.57% to $2.63 with a turnover of $395.04 million. $ClearOne(CLRO.US)$ soars 110.97% to $1.

Futu NewsMar 13 02:00

12 Health Care Stocks Moving In Tuesday's Intraday Session

GainersRegulus Therapeutics (NASDAQ:RGLS) stock increased by 94.9% to $2.69 during Tuesday's regular session. The company's market cap stands at $54.3 million. Bright Green (NASDAQ:BGXX) shares increa

BenzingaMar 13 01:31

Bright Green to Expand Drug Production Plant With $250 Million Project

By Dean Seal Bright Green has signed a $250 million deal to expand its facility in New Mexico for the production and processing of cannabis and other federally illegal drugs. The company said Tuesda

WSJMar 12 23:38

Bright Green Corp Signed An Agreement With Dalsem Greenhouse Technologies BV For $250M For Expansion Of Its Controlled Substances Drug Production Facility In Grants, New Mexico And Obtained $60M In Financing

Bright Green Corporation (NASDAQ:BGXX) ("Bright Green" or the "Company") today announced that it has signed an agreement with Dalsem Greenhouse Technologies BV for a $250 million construction project to expand the Company's current research, production and extraction processing facility located in rural Grants, New Mexico (the "Dalsem Agreement").

BenzingaMar 12 23:02

BRIGHT GREEN ANNOUNCES PLANS FOR $250 MILLION EXPANSION OF ITS CONTROLLED SUBSTANCES DRUG PRODUCTION FACILITY IN GRANTS, NEW MEXICO AND OBTAINS $60 MILLION IN FINANCING

Bright Green Corporation (Nasdaq: BGXX) today announced that it has signed an agreement with Dalsem Greenhouse Technologies BV for a $250 million construction project to expand the Company's current research, production and extraction processing facility located in rural Grants, New Mexico (the "Dalsem Agreement").

GlobeNewswireMar 12 22:59

Bright Green Corp Enhances Leadership and Governance

TipRanksMar 12 04:23

Bright Green Corporation Submits For DEA Registration For Production Of Schedule I And Schedule II Controlled Substances

Bright Green Corporation announced today the submission of its DEA Registration for Bulk Production of Schedule I and Schedule II Controlled Substances.

BenzingaMar 7 21:16

DEA Clears This NASDAQ-Traded 'Plant-Touching' Firm To Research And Produce Schedule I And II Plant-Based Drugs

Bright Green Corporation (NASDAQ:BGXX) announced on Thursday that it has received final approval from the New Mexico Board of Pharmacy and the DEA to register, license and authorize Schedule I and Sch

BenzingaFeb 24 04:10

Bright Green Shares Up 43% on 'Unique Licensing' for Schedule I and II Drugs

By Josh Beckerman Bright Green shares were recently up 43% to 27 cents Thursday after the company received final approval for "unique licensing" for certain drugs from the New Mexico Board of Pharmac

WSJFeb 23 03:00

Bright Green Secures DEA Approval for Drug Research

InvestingFeb 23 02:40